References
- Epilepsy Foundation of America. Basic statistics on the epilepsies. Philadelphia: FA Davis. 1975
- Kutt H, Penry JK. Usefulness of blood levels of antiepileptic drugs. Arch Neurol 1974: 31(5): 283–8
- Wilder BJ, Bruni J. Seizure disorders: a pharmacological approach to treatment. New York: Raven Press. 1981
- Penry JK, Newmark ME. The use of antiepileptic drugs. Ann Intern Med 197930(2): 207–18
- Engel J Jr. Troupin AS, Crandall PH, et al. Recent developments in the diagnosis and therapy of epilepsy. Ann Intern Med 1982: 97(4): 584–98
- Pippenger CE, Penry JK, White BG, et al. Interlaboratory variability in determination of plasma antiepileptic drug concentrations. Arch Neurol 1976: 33(5): 351–5
- Troupin A, Ojemann LM, Halpern L, et al Carbamazepin: a double-blind comparison with Phenytoin. Neurology (Minneap) 1977: 27(6): 511–9
- Perucca E. Pharmacokinetic interactions with antiepileptic drugs. Clin Pharmacokinet 1982: 7(1): 57–84
- Somogyi A. Gugler R. Drug interactions with Cimetidine. Clin Pharmacokinet 1982: 7(1): 23–41
- Delgado-Escueta AV, Wasterlain C. Treiman DM, et al. Management of status epilepticus. N Engl J Med 1982: 306(22): 1337–40
- Cloyd JC, Gumnit RJ, McLain LW Jr. Status epilepticus: the role of Intravenous Phenytoin. JAMA 1980: 244(13): 1479–81
- Mullen FW. Optimal Phenytoin therapy: a new technique for individualizing dosage. Clin Pharmacol Ther 1978: 23(2): 228–32